Different thresholds of Notch signaling bias human precursor cells toward B-, NK-, monocytic/dendritic-, or T-cell lineage in thymus microenvironment

Blood

Volumn 106, Issue 10, 2005, Pages 3498-3506

  De Smedt, Magda ^a   Hoebeke, Inge ^a   Reynvoet, Katia ^a   Leclercq, Georges ^a   Plum, Jean ^a  

^a GHENT UNIVERSITY HOSPITAL   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

7 [N[N (3,5 DIFLUOROPHENYL)ALANYL]PHENYL GLYCINE TERT BUTYL ESTER]; CD1 ANTIGEN; CD34 ANTIGEN; CD4 ANTIGEN; CD8 ANTIGEN; GAMMA SECRETASE INHIBITOR; NOTCH RECEPTOR; T LYMPHOCYTE RECEPTOR BETA CHAIN; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; B LYMPHOCYTE; CELL DIFFERENTIATION; CELL LINEAGE; CELL MATURATION; CELL TYPE; CONCENTRATION RESPONSE; CONTROLLED STUDY; DENDRITIC CELL; FETUS; GENE LOCUS; GENETIC RECOMBINATION; HEMATOPOIESIS; HUMAN; HUMAN CELL; HUMAN TISSUE; MONOCYTE; MOUSE; NATURAL KILLER CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN FUNCTION; SIGNAL TRANSDUCTION; STEM CELL; T LYMPHOCYTE; THYMUS; UMBILICAL CORD BLOOD;

EID: 27744509876     PISSN: 00064971     EISSN: 00064971     Source Type: Journal    
DOI: 10.1182/blood-2005-02-0496     Document Type: Article

References (53)

1. Ramiro AR, Trigueros C, Marquez C, San Millan JL, Toribio ML. Regulation of pre-T cell receptor (pT alpha-TCR beta) gene expression during human thymic development. J Exp Med. 1996;184:519-530.
2. Spits H. Development of αβ T cells in the human thymus. Nat Rev Immunol. 2002;2:760-772.
3. Artavanis-Tsakonas S, Rand MD, Lake RJ. Notch signalling: cell fate control and signal integration in development. Science. 1999;284:770-776.
4. Radtke F, Wilson A, MacDonald HR. Notch signalling in T- and B-cell development. Curr Opin Immunol. 2004;16:174-179.
5. Radtke F, Wilson A, Mancini SJ, MacDonald HR. Notch regulation of lymphocyte development and function. Nat Immunol. 2004;5:247-253.
6. Maillard I, Adler SH, Pear WS. Notch and the immune system. Immunity. 2003;19:781-791.
7. Radtke F, Wilson A, Stark G, et al. Deficient T cell fate specification in mice with an induced inactivation of Notch1. Immunity. 1999;10:547-558.
8. Koch U, Lacombe TA, Holland D, et al. Subversion of the T/B lineage decision in the thymus by lunatic fringe-mediated inhibition of Notch-1. Immunity. 2001;15:225-236.
9. Izon DJ, Aster JC, He Y, et al. Deltex1 redirects lymphoid progenitors to the B cell lineage by antagonizing Notch1. Immunity. 2002;16:231-243.
10. Robey E, Chang D, Itano A, et al. An activated form of Notch influences the choice between CD4 and CD8 T cell lineages. Cell. 1996;87:483-492.
11. Deftos ML, Huang E, Ojala EW, Forbush KA, Bevan MJ. Notch1 signalling promotes the maturation of CD4 and CD8 SP thymocytes. Immunity. 2000;13:73-84.
12. Washburn T, Schweighoffer E, Gridley T, et al. Notch activity influences the αβ versus γδ T cell lineage decision. Cell. 1997;88:833-843.
13. Wolfer A, Bakker T, Wilson A, et al. Inactivation of Notch 1 in immature thymocytes does not perturb CD4 or CD8T cell development. Nat Immunol. 2001;2:235-241.
14. Wolfer A, Wilson A, Nemir M, MacDonald HR, Radtke F. Inactivation of Notch1 impairs VDJβ rearrangement and allows pre-TCR-independent survival of early alpha beta lineage thymocytes. Immunity. 2002;16:869-879.
15. Mestas J, Hughes CC. Of mice and not men: differences between mouse and human immunology. J Immunol. 2004;172:2731-2738.
16. Rothenberg EV, Yui MA, Telfer JC. T-cell developmental biology. In: Paul WE, ed. Fundamental Immunology. 5th ed. Philadelphia, PA: Lippincott Williams & Wilkins; 2003:259-319.
17. De Smedt M, Reynvoet K, Kerre T, et al. Active form of Notch imposes T cell fate in human progenitor cells. J Immunol. 2002;169:3021-3029.
18. Garcia-Peydro M, de Yebenes VG, Toribio ML. Sustained Notch1 signalling instructs the earliest human intrathymic precursors to adopt a γδ T-cell fate in fetal thymus organ culture. Blood. 2003;102:2444-2451.
19. La Motte-Mohs RN, Herer E, Zuniga-Pflucker JC. Induction of T cell development from human cord blood hematopoietic stem cells by Delta-like 1 in vitro. Blood. 2005;105:1431-1439.
20. De Smedt M, Hoebeke I, Plum J. Human bone marrow CD34+ progenitor cells mature to T cells on OP9-DL1 stromal cell line without thymus microenvironment. Blood Cell Mol Dis. 2004;33:227-232.
21. De Strooper B, Annaert W, Cupers P, et al. A presenilin-1-dependent gamma-secretase-like protease mediates release of Notch intracellular domain. Nature. 1999;398:518-522.
22. Selkoe DJ. Presenilin, Notch, and the genesis and treatment of Alzheimer's disease. Proc Natl Acad Sci U S A. 2001;98:11039-11041.
23. Doerfler P, Shearman MS, Perlmutter RM. Presenilin-dependent gamma-secretase activity modulates thymocyte development. Proc Natl Acad Sci U S A. 2001;98:9312-9317.
24. Hadland BK, Manley NR, Su D, et al. Gamma-secretase inhibitors repress thymocyte development. Proc Natl Acad Sci U S A. 2001;98:7487-7491.
25. Plum J, De Smedt M, Defresne MP, Leclercq G, Vandekerckhove B. Human CD34+ fetal liver stem cells differentiate to T cells in a mouse thymic microenvironment. Blood. 1994;84:1587-1593.
26. Plum J, De Smedt M, Leclercq G, Verhasselt B, Vandekerckhove B. Interleukin-7 is a critical growth factor in early human T-cell development. Blood. 1996;88:4239-4245.
27. Unkeless JC. Characterization of a monoclonal antibody directed against mouse macrophage and lymphocyte Fc receptors. J Exp Med. 1979;150:580-596.
28. Schmid I, Uittenbogaart CH, Giorgi JV. A gentle fixation and permeabilization method for combined cell surface and intracellular staining with improved precision in DNA quantification. Cytometry. 1991;12:279-285.
29. Taghon T, Stolz F, De Smedt M, et al. HOX-A10 regulates hematopoietic lineage commitment: evidence for a monocyte-specific transcription factor. Blood. 2002;99:1197-1204.
30. Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods. 2001;25:402-408.
31. Ktorza S, Blanc C, Laurent C, et al. Complete TCR-delta rearrangements and partial (D-J) recombination of the TCR-beta locus in CD34+7+ precursors from human cord blood. J Immunol. 1996;156:4120-4127.
32. Toyonaga B, Yoshikai Y, Vadasz V, Chin B, Mak TW. Organization and sequences of the diversity, joining, and constant region genes of the human T-cell receptor beta chain. Proc Natl Acad Sci U S A. 1985;82:8624-8628.
33. Ktorza S, Sarun S, Rieux-Laucat F, de Villartay JP, Debre P, Schmitt C. CD34-positive early human thymocytes: T cell receptor and cytokine receptor gene expression. Eur J Immunol. 1995;25:2471-2478.
34. Van Den Brandt J, Voss K, Schott M, Hunig T, Wolfe MS, Reichardt HM. Inhibition of Notch signalling biases rat thymocyte development towards the NK cell lineage. Eur J Immunol. 2004;34:1405-1413.
35. Ohishi K, Varnum-Finney B, Bernstein ID. Delta-1 enhances marrow and thymus repopulating ability of human CD34(+)CD38(-) cord blood cells. J Clin Invest. 2002;110:1165-1174.
36. Robertson M, Ritz J. Biology and clinical relevance of human natural killer cells. Blood. 1990;76:2421-2438.
37. Lopez-Cabrera M, Santis A, Fernandez-Ruiz E, et al. Molecular cloning, expression, and chromosomal localization of the human earliest lymphocyte activation antigen AIM/CD69, a new member of the C-type animal lectin superfamily of signal-transmitting receptors. J Exp Med. 1993;178:537-547.
38. Blom B, Verschuren MCM, Heemskerk MHM, et al. TCR gene rearrangements and expression of the pre-T cell receptor complex during human T-cell differentiation. Blood. 1999;93:3033-3043.
39. Harman BC, Jenkinson EJ, Anderson G. Entry into the thymic microenvironment triggers Notch activation in the earliest migrant T cell progenitors. J Immunol. 2003;170:1299-1303.
40. Weekx SF, Snoeck HW, Offner F, et al. Generation of T cells from adult human hematopoietic stem cells and progenitors in a fetal thymic organ culture system: stimulation by tumor necrosis factor-alpha. Blood. 2000;95:2806-2812.
41. Dovey HF, John V, Anderson JP, et al. Functional gamma-secretase inhibitors reduce beta-amyloid peptide levels in brain. J Neurochem. 2001;76:173-181.
42. Ohishi K, Varnum-Finney B, Bernstein ID. The notch pathway: modulation of cell fate decisions in hematopoiesis. Int J Hematol. 2002;75:449-459.
43. Milner LA, Bigas A. Notch as a mediator of cell fate determination in hematopoiesis: evidence and speculation. Blood. 1999;93:2431-2448.
44. Izon DJ, Punt JA, Pear WS. Deciphering the role of Notch signalling in lymphopoiesis. Curr Opin Immunol. 2002;14:192-199.
45. Maillard I, He Y, Pear WS. From the yolk sac to the spleen: new roles for Notch in regulating hematopoiesis. Immunity. 2003;18:587-589.
46. Berardi AC, Meffre E, Pflumio F, et al. Individual CD34+CD38lowCD19-CD10- progenitor cells from human cord blood generate B lymphocytes and granulocytes. Blood. 1997;89:3554-3564.
47. Schmitt TM, Ciofani M, Petrie HT, Zuniga-Pflucker JC. Maintenance of T cell specification and differentiation requires recurrent Notch receptor-ligand interactions. J Exp Med. 2004;200:469-479.
48. Porritt HE, Rumfelt LL, Tabrizifard S, Schmitt TM, Zuniga-Pflucker JC, Petrie HT. Heterogeneity among DN1 prothymocytes reveals multiple progenitors with different capacities to generate T cell and non-T cell lineages. Immunity. 2004;20:735-745.
49. Heinly CS, Sempowski GD, Lee DM, et al. Comparison of thymocyte development and cytokine production in CD7-deficient, CD28-deficient and CD7/CD28 double-deficient mice. Int Immunol. 2001;13:157-166.
50. Bonilla F, Kokron C, Swinton P, Geha R. Targeted gene disruption of murine CD7. Int Immunol. 1997;9:1875-1883.
51. Dallas MH, Varnum-Finney B, Delaney C, Kato K, Bernstein ID. Density of the Notch ligand Delta1 determines generation of B and T cell precursors from hematopoietic stem cells. J Exp Med. 2005;201:1361-1366.
52. Marklund U, Lightfoot K, Cantrell D. Intracellular location and cell context-dependent function of protein kinase D. Immunity. 2003;19:491-501.
53. Hinton HJ, Alessi DR, Cantrell DA. The serine kinase phosphoinositide- dependent kinase 1 (PDK1) regulates T cell development. Nat Immunol. 2004;5:539-545.